Ongoing Clinical Trials in Testicular Cancer: The TIGER Trial | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Ongoing Clinical Trials in Testicular Cancer: The TIGER Trial

Publication year - 2016

Publication title -

oncology research and treatment

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.553

H-Index - 48

eISSN - 2296-5262

pISSN - 2296-5270

DOI - 10.1159/000448868

Subject(s) - tiger , testicular cancer , clinical trial , cancer , medicine , oncology , computer science , computer security

In France by the PHRC (le programme hospitalier de recherche clinique), in Italy by AIFA (Agenzia Italiana del Farmaco) and in the UK by CRUK (Cancer Research UK) and the Orchid Foundation. For Germany, a grant application at the Deutsche Krebshilfe (DKH) is currently under review. The trial has been designed to prospectively assess the impact of sequential high-dose chemotherapy given at first relapse compared to conventional-dose standard chemotherapy on patients’ overall survival (OS) (primary outcome measure), as well as progressionfree survival (PFS), favorable response rate and clinically relevant parameters such as treatment related toxicity and mortality, impact of tumor marker decline rates on OS and PFS, a prospective evaDescription

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research